Form 4: Health Catalyst COO Sells Shares for Tax Obligations

Health Catalyst's Chief Operating Officer, Daniel LeSueur, disposed of 3,663 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Summary

• Daniel LeSueur, Chief Operating Officer of Health Catalyst, Inc. (HCAT), disposed of 3,663 shares of common stock.
• The transaction occurred on September 2, 2025, at a price of $3.3627 per share.
• This sale was non-discretionary, mandated by the company's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs).
• Following this transaction, LeSueur beneficially owns 198,367 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax purposes, which is neutral in terms of sentiment. It does not indicate a change in management's confidence or company performance.

Future Outlook

NA

Management Comments

• This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

This is a routine insider transaction (Form 4) related to executive compensation and tax obligations, which does not typically reflect broader industry trends or competitive positioning. Such transactions are common across publicly traded companies where executives receive equity compensation.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders as it is a routine, non-discretionary sale for tax purposes, not reflecting a change in the executive's investment thesis or company performance. It is a standard part of executive equity compensation management.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary 'sell to cover' transaction by an executive to satisfy tax obligations related to vested restricted stock units. Such transactions are common and do not typically signal a change in the company's fundamentals or the executive's confidence. Therefore, it provides no new information that would warrant a change in an existing investment thesis, leading to a 'hold' recommendation based solely on this filing.

Keywords

Health Catalyst, HCAT, Insider Trading, Form 4, Daniel LeSueur, Stock Sale, Restricted Stock Units, Tax Withholding